These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3876227)

  • 1. Oxidation by rat brain of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) coupled to tetrazolium nitro blue.
    Youdim MB
    Eur J Pharmacol; 1985 Jul; 113(2):283-6. PubMed ID: 3876227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary.
    Gibb C; Willoughby J; Glover V; Sandler M; Testa B; Jenner P; Marsden CD
    Neurosci Lett; 1987 May; 76(3):316-22. PubMed ID: 3495757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
    Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues.
    Glover V; Gibb C; Sandler M
    Neurosci Lett; 1986 Feb; 64(2):216-20. PubMed ID: 3083305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP.
    Salach JI; Singer TP; Castagnoli N; Trevor A
    Biochem Biophys Res Commun; 1984 Dec; 125(2):831-5. PubMed ID: 6335034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Oct; 45(4):1049-54. PubMed ID: 3928814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP; Salach JI; Castagnoli N; Trevor A
    Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N
    J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
    Youngster SK; McKeown KA; Jin YZ; Ramsay RR; Heikkila RE; Singer TP
    J Neurochem; 1989 Dec; 53(6):1837-42. PubMed ID: 2809594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK; Youngster SK; Kindt MV; Heikkila RE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
    Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):648-52. PubMed ID: 3488394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liver.
    Arora PK; Riachi NJ; Harik SI; Sayre LM
    Biochem Biophys Res Commun; 1988 May; 152(3):1339-47. PubMed ID: 3259874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T; Arán VJ; Guillén H
    Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
    FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
    Heikkila RE; Duvoisin RC; Finberg JP; Youdim MB
    Eur J Pharmacol; 1985 Oct; 116(3):313-7. PubMed ID: 3935467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro.
    Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
    J Neural Transm Suppl; 1986; 22():55-60. PubMed ID: 3097260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.